Literature DB >> 26930555

Analysis of the Stromal Cellular Components of the Solid Tumor Microenvironment Using Flow Cytometry.

Michael Timaner1, Ofrat Beyar-Katz1, Yuval Shaked1.   

Abstract

The tumor microenvironment consists of a variety of cell types. The contribution of each cell type to the tumor is an emerging subject in the field of cancer research. Here, we describe protocols for dissociating tumor tissues and Matrigel plugs into single cells for further analysis by flow cytometry. These protocols can be used for evaluating the cellular component of solid tumors from human or mouse origin or Matrigel plugs implanted in mice. The protocols describe the dissociation of tumor tissue with or without dissociation automatic devices. Subsequently, the use of flow cytometry for immunophenotypic analysis of host cells found in the tumor microenvironment, including myeloid derived suppressor cells, endothelial cells, and macrophages is provided. These methods can be used to broaden our understanding of the cross-talk between tumor and host cells in the tumor microenvironment. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  bone marrow derived cells; cancer cells; cell dissociation; host

Mesh:

Substances:

Year:  2016        PMID: 26930555     DOI: 10.1002/0471143030.cb1918s70

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  9 in total

1.  Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.

Authors:  Michael Timaner; Nitzan Letko-Khait; Ruslana Kotsofruk; Madeleine Benguigui; Ofrat Beyar-Katz; Chen Rachman-Tzemah; Ziv Raviv; Tomer Bronshtein; Marcelle Machluf; Yuval Shaked
Journal:  Cancer Res       Date:  2018-01-04       Impact factor: 12.701

Review 2.  Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses.

Authors:  Alexandre Morrot; Leonardo Marques da Fonseca; Eduardo J Salustiano; Luciana Boffoni Gentile; Luciana Conde; Alessandra Almeida Filardy; Tatiany Nunes Franklim; Kelli Monteiro da Costa; Celio Geraldo Freire-de-Lima; Leonardo Freire-de-Lima
Journal:  Front Oncol       Date:  2018-03-23       Impact factor: 6.244

3.  ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription.

Authors:  Shimrit Avraham; Ben Korin; Sharon Aviram; Dvir Shechter; Yuval Shaked; Ami Aronheim
Journal:  Oncogene       Date:  2019-01-22       Impact factor: 9.867

Review 4.  Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer.

Authors:  Sabah Nisar; Ajaz A Bhat; Sheema Hashem; Santosh K Yadav; Arshi Rizwan; Mayank Singh; Puneet Bagga; Muzafar A Macha; Michael P Frenneaux; Ravinder Reddy; Mohammad Haris
Journal:  J Transl Med       Date:  2020-12-09       Impact factor: 5.531

5.  Photopharmacological modulation of native CRAC channels using azoboronate photoswitches.

Authors:  Ronald Udasin; Anwesha Sil; Elia Zomot; Hadas Achildiev Cohen; Jozafina Haj; Nurit Engelmayer; Shaya Lev; Alexander M Binshtok; Yuval Shaked; Michael A Kienzler; Raz Palty
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-21       Impact factor: 12.779

6.  The antiangiogenic role of the pro-inflammatory cytokine interleukin-31.

Authors:  Shiri Davidi; Ella Fremder; Tal Kan; Ziv Raviv; Michael Timaner; Nathan Karin; Dov Hershkovitz; Ami Arohneim; Yuval Shaked
Journal:  Oncotarget       Date:  2017-03-07

7.  CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo.

Authors:  Rarastoeti Pratiwi; Nyoman Yudi Antara; Lalu Gunawan Fadliansyah; Syamsul Arif Ardiansyah; Luthfi Nurhidayat; Eti Nurwening Sholikhah; Sunarti Sunarti; Sitarina Widyarini; Ahmad Ghitha Fadhlurrahman; Hindana Fatmasari; Woro Anindito Sri Tunjung; Sofia Mubarika Haryana; Firman Alamsyah; Warsito Purwo Taruno
Journal:  F1000Res       Date:  2019-10-17

8.  IL-31 induces antitumor immunity in breast carcinoma.

Authors:  Ami Aronheim; Yuval Shaked; Tal Kan; Erik Feldman; Michael Timaner; Ziv Raviv; Shai Shen-Orr
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

9.  Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer.

Authors:  Maryna Bondarenko; Marion Le Grand; Yuval Shaked; Ziv Raviv; Guillemette Chapuisat; Cécile Carrère; Marie-Pierre Montero; Mailys Rossi; Eddy Pasquier; Manon Carré; Nicolas André
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.